RxDoctor Payments Data

Meklit Zetawos

Physician Assistant · Wichita, KSNPI 1528305372

Payments from drug & device makers

$5,556in general payments, 2019–2025

Across 283 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$905
  • Medtronic$824
  • Inspire Medical Systems, Inc.$753
  • Takeda Pharmaceuticals U.S.A., Inc.$584
  • AbbVie$512
  • Lilly USA, LLC$253
  • plus $2K from 26 others

What the payments were for

  • Travel & lodging$2835%
  • Food & beverage$4,93389%
  • Education$3406%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,556 in reported general payments places this provider in the 90th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas

Medicare billing

Part B allowed, 2024
$110,212
Medicare patients
352
Services billed
3,339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$21,783
LinzessLinaclotide17$14,377
XareltoRivaroxaban16$14,290
TrulancePlecanatide21$12,770
Omeprazole154$1,168
Budesonide DrBudesonide11$858
Pantoprazole Sodium98$721
Sucralfate14$650
Famotidine96$577
Esomeprazole Magnesium21$524
Ondansetron OdtOndansetron28$478
Potassium Chloride23$325
ClopidogrelClopidogrel Bisulfate34$263
Dicyclomine Hcl19$207
Metoprolol Tartrate34$202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$101$21,78321 claims
AbbVieLinzess$512$14,37717 claims
Johnson & JohnsonXarelto$905$14,29016 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$45$12,77021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,016 physician assistant providers in Kansas.

Other physician assistant in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →